Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

Dear Doctors: I am a healthy 23-year-old woman. I started noticing extra hairs in my brush, and then my mom found two bald spots on the back of my head.

In a large cohort study, patients with ASDs have significantly better all-cause and cancer-specific survival after antineoplastic therapy compared with those without an autoimmune skin disease.

New study in Stem Cell Research & Therapy reveals biological pathways behind hair loss, potential new treatments.

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

Dallas Cowboys Cheerleaders,' fifth-year veteran and group leader Armani Latimer announced her retirement from the team. Here ...

Fiancé star reveals a chronic health condition that impacts her appearance, sparking concern among fans who say it “looks so ...